TXMD - TherapeuticsMD's (TXMD) CEO Rob Finizio on Q2 2021 Results - Earnings Call Transcript
TherapeuticsMD, Inc. (TXMD) Q2 2021 Earnings Conference Call August 4, 2021 8:30 AM ET Company Participants Lisa Wilson – Investor Relations Rob Finizio – Chief Executive Officer James D’Arecca – Chief Financial Officer Dawn Halkuff – Chief Commercial Officer Mitchell Krassan – Chief Strategy and Performance Officer Conference Call Participants Louise Chen – Cantor Annabel Samimy – Stifel Douglas Tsao – H.C. Wainwright Presentation Operator Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD Second Quarter 2021 Financial Results Conference Call. Following the prepared remarks from the company, we will open the call for questions. I would now like to turn the call over to Investor Relations for TherapeuticsMD, Lisa Wilson. Lisa? Lisa Wilson Thank you, Christy. Good morning, everyone, and thank you for joining us today to discuss our second quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our
For further details see:
TherapeuticsMD's (TXMD) CEO Rob Finizio on Q2 2021 Results - Earnings Call Transcript